Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Roquefort Thera (ROQ) Share News

IN BRIEF: Roquefort Therapeutics sees positive results in cancer study

11th Oct 2022 13:14

Roquefort Therapeutics PLC - London-based biotech company - Will present results from its anti-cancer RNA pre-clinical study on Tuesday afternoon at European Society of Gene & Cell Therapy in Edinburgh. Results show that a splice switching RNA medicine can impair Midkine action. RNA turns genetic information into proteins. Midkine appears to enhance the proliferative features of cancer. Roquefort treatment reduces full length Midkine and generates a "non-functional shortened Midkine" by inducing a change in the Midkine mRNA. Read More

Roquefort Therapeutics losses widen but boasts strong cash balance

23rd Sep 2022 09:28

(Alliance News) - Roquefort Therapeutics PLC on Friday reported a widened pretax loss but maintained a strong cash balance. Read More

Roquefort Therapeutics completes Oncogeni deal for GBP5.5 million

16th Sep 2022 09:40

(Alliance News) - Roquefort Therapeutics PLC on Friday said it completed its acquisition of cancer-focused biotech firm Oncogeni Ltd for GBP5.5 million. Read More

IN BRIEF: Roquefort pleased with MDK in vitro experiments

11th Aug 2022 19:06

Roquefort Therapeutics PLC - London-based biotechnology company - Says Midkine in vitro experiments completed with company's oligonucleotides reducing high MDK levels in cancer cells. "These positive results demonstrate the pre-clinical proof of principle in cancer for the antisense oligonucleotide drug development program and underpin the company's ability to progress to in vivo studies and clinical trials in due course targeting MDK in cancer," it says. On patent portfolio, has filed patents in Australia and UK to protect the composition of truncated MDK, mRNAs and antisense oligonucleotides. Adds it is working on publishing a prospectus, completing the acquisition of Oncogeni Ltd and GBP1.0 million fundraise. Read More

TRADING UPDATES: Premier Miton assets dip; Challenger Energy CFO quits

15th Jul 2022 21:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

23rd Jun 2022 16:02

TRADING UPDATES: Vertu margins remain strong; Donegal behind

22nd Jun 2022 19:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Roquefort Therapeutics seeing "encouraging" results

7th Jun 2022 21:19

Roquefort Therapeutics PLC - London-based biotechnology company - During the first half of 2022, the company says it has focused on progressing its collaboration with Murdoch University in Australia and reviewing its portfolio. Chair Stephen West says it has been a "very active start" to the year with "significant progress" made. Read More

Roquefort posts loss, remains optimistic after Lyramid acquisition

11th May 2022 16:35

(Alliance News) - Biotech company Roquefort Therapeutics PLC on Wednesday reported a loss but was upbeat on its future after the takeover of Australian business Lyramid. Read More

TRADING UPDATES: Kavango eyes acquisition; PYX ups zicron price

21st Mar 2022 19:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: BioPharma backs Collegium; Eurasia creates Kola

14th Feb 2022 22:19

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News: Read More